UPDATE : Monday, September 7, 2020
상단여백
Immunotherapies Opdivo, Keytruda score high in real setting by Kim Eun-young 2019-09-10 12:49
'Xarelto has superior renal preservation benefits in atrial fibrillation patients’ by Lee Han-soo 2019-09-09 16:54
Hanmi to unveil investigator-led P2 progress for cancer treatment by Lee Han-soo 2019-09-09 15:47
Novo Nordisk's Ryzodeg leads Korean mixed insulin market by Lee Han-soo 2019-09-09 14:18
PARP inhibitors to show intense rivalry at ESMO 2019 by Kim Yun-mi 2019-09-09 11:56
라인
Ildong to sell GSK’s influenza treatment by Lee Han-soo 2019-09-06 17:02
Yuhan to expand biz scope to central nervous system disease by Jeong Sae-im 2019-09-06 14:56
Seoul Pharmaceutical to export erectile dysfunction treatment to Taiwan by Lee Han-soo 2019-09-05 17:04
Lilly’s migraine treatment Emgality lands in Korea by Lee Hye-seon 2019-09-05 16:24
Daewoong, Medytox squabble over appraisal of additional spore for Nabota by Lee Han-soo 2019-09-05 14:35
라인
[News analysis] Takeda Korea’s merger with Shire has to surmount big hurdle; labor union by Lee Han-soo 2019-09-04 17:06
JW Pharmaceutical acquires Vietnamese drugmaker by Lee Han-soo 2019-09-04 15:16
Takeda Korea vows to release 16 new drugs by 2023 by Kim Yun-mi 2019-09-03 15:40
SK goes global by developing new drugs, conducting CDMO biz by Jeong Sae-im 2019-09-03 14:58
Hanmi, Daewoong among 20 innovative top-tier drugmakers in Asia Pacific by Jeong Sae-im 2019-09-02 17:33
라인
Antidiabetic Forxiga proves efficacy in heart failure by Kim Yun-mi 2019-09-02 11:35
Daewoong, Medytox differ in interpreting spore appraisal for Nabota by Lee Han-soo 2019-08-30 16:26
Atopic dermatitis patients fall in despair as Dupixent may not get coverage soon by Kim Yun-mi 2019-08-30 16:26
Doctors seem less eager to participate in ‘No-Japan’ campaign. Why? by Lee Han-soo 2019-08-30 15:58
JW Pharmaceutical’s hyperlipidemia drug Livalo safe from diabetes risk by Jeong Sae-im 2019-08-30 14:49
여백
여백
여백
Back to Top